Are these blood results consistent with Polycystic Ovary Syndrome (PCOS) and what is the impact on ovulatory function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Analysis of Blood Results for PCOS and Ovulatory Function

Cannot Definitively Assess PCOS or Ovulatory Function with Current Hormonal Contraception

Your blood results cannot be reliably interpreted for PCOS diagnosis while the Implanon (etonogestrel implant) is in place, as the progestin suppresses the hypothalamic-pituitary-ovarian axis and makes hormone levels unreliable for diagnosing PCOS. 1

Why These Results Are Uninterpretable

The progestin-only implant fundamentally alters the hormonal landscape needed for PCOS diagnosis:

  • LH/FSH ratio becomes meaningless: Progestin suppression of gonadotropin secretion eliminates the characteristic elevated LH or elevated LH/FSH ratio (>2) seen in many PCOS patients 1, 2
  • Testosterone interpretation is compromised: While total testosterone via LC-MS/MS is the best single biochemical marker for PCOS (74% sensitivity, 86% specificity), progestin-induced changes in SHBG and suppressed ovarian function alter the hormonal context 1
  • Ovulatory function cannot be assessed: The implant is designed to suppress ovulation, so any assessment of natural ovulatory function is impossible while it remains in place 1

What Your Ultrasound Shows: Not PCOS

Your ovarian volumes actually argue against PCOS:

  • Right ovary: 4.56cc - This is normal and well below the PCOS threshold 3, 4
  • Left ovary: 1.05cc - This is concerningly small, suggesting diminished ovarian reserve rather than PCOS 3, 4

PCOS requires ovarian volume >10 mL (10cc) in at least one ovary, and neither of your ovaries meets this criterion. 3, 1 The diagnostic threshold for polycystic ovarian morphology is ≥20 follicles (2-9mm diameter) per ovary OR ovarian volume >10mL using transvaginal ultrasound with ≥8 MHz transducer frequency 3, 1

Primary Concern: Diminished Ovarian Reserve

Your left ovary volume of 1.05cc is below the 3 cm³ threshold that suggests diminished ovarian reserve, which is a concerning finding requiring additional workup. 3, 4

When ovarian volume is <3 cm³ and <5 antral follicles are present, this suggests diminished ovarian reserve 3, 4. The combination of irregular periods with a small ovary volume raises concern for premature ovarian insufficiency (POI) or primary ovarian failure, particularly if you are under 40 years old 4.

Required Next Steps for Accurate Assessment

To properly evaluate for PCOS and ovulatory function, you must:

  1. Remove the Implanon or wait for it to expire before hormonal testing 1

  2. Wait 2-3 months after removal to allow your natural hormonal axis to recover before testing 1

  3. Then obtain proper diagnostic testing:

    • Total testosterone via LC-MS/MS (not immunoassay) 1, 2
    • Calculated free testosterone using the Vermeulen equation 1, 2
    • LH and FSH measured between cycle days 3-6 2
    • Mid-luteal progesterone to confirm ovulation (levels <6 nmol/L indicate anovulation) 2
    • TSH to rule out thyroid disease 2
    • Prolactin (morning resting levels) to exclude hyperprolactinemia 2
    • AMH level (though not diagnostic alone, <35 pmol/L would support diminished ovarian reserve) 1, 4
    • Antral follicle count on ultrasound (<5 antral follicles combined with low ovarian volume strongly suggests diminished reserve) 3, 4
  4. Metabolic screening regardless of PCOS diagnosis:

    • Two-hour oral glucose tolerance test with 75g glucose load 2
    • Fasting lipid panel 2

Clinical Pitfalls to Avoid

  • Do not dismiss the small left ovary as insignificant asymmetry - this degree of volume discrepancy warrants investigation for unilateral ovarian pathology or systemic ovarian dysfunction 4
  • Do not pursue PCOS workup when ovarian volumes are normal and clinical hyperandrogenism is absent - this leads to misdiagnosis and inappropriate treatment 4
  • Do not rely on AMH alone for diagnosis - AMH levels are elevated in PCOS but not yet recommended for clinical diagnosis due to lack of standardization and established cut-offs 3, 1

Can PCOS Be Diagnosed Without Abnormal Labs?

Yes, but only with the right clinical picture. A woman can be diagnosed with PCOS based solely on clinical hyperandrogenism (hirsutism, acne, or alopecia) plus irregular menstrual cycles, without any abnormal laboratory values, according to the Rotterdam criteria. 2 However, this requires documented clinical hyperandrogenism and menstrual irregularity that persists off hormonal contraception 1, 2.

Total testosterone is abnormal in only 70% of women with confirmed PCOS, meaning 30% have normal testosterone levels despite having the condition 2. The LH/FSH ratio >2 is abnormal in only 35-44% of women with PCOS, making it a poor diagnostic marker 2.

Bottom Line

Your current blood work cannot confirm or exclude PCOS while on Implanon, and your ultrasound findings suggest diminished ovarian reserve rather than PCOS. 1, 4 Remove the implant, wait 2-3 months, then obtain comprehensive hormonal testing to properly assess both PCOS and ovulatory function 1. The small left ovary requires specific attention and may indicate a more significant reproductive health concern than PCOS 3, 4.

References

Guideline

Diagnostic Criteria and Treatment Options for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Evaluations for Suspected Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ovarian Asymmetry and Diminished Ovarian Reserve

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the risks for a 24-year-old female (F) patient with polycystic ovary syndrome (PCOS) who wishes to discontinue metformin (Metformin) and spironolactone (Aldactone) due to not wanting children?
Should a 38-year-old female with a history of Polycystic Ovary Syndrome (PCOS), Hypertension (HTN), Obesity (Body Mass Index (BMI) 37), and Pre-diabetes Mellitus (Pre-DM) be given progesterone to induce withdrawal bleeding after experiencing amenorrhea for 2 years, despite no response to previous progesterone courses, and does she require further evaluation with imaging or biopsies?
What are the next steps for a 22-year-old morbidly obese female with hypercortisolism (elevated cortisol), as indicated by an adrenocorticotropic hormone (ACTH) level of 87 and a cortisol level of 27, who has a suppressed ACTH (<5) and cortisol level (1.9) after a dexamethasone suppression test (DST), along with elevated androgen levels, including dehydroepiandrosterone sulfate (DHEAS) of 312, androstenedione of 401, and testosterone of 12.5, as well as an anti-müllerian hormone (AMH) of 20.15, 17-hydroxyprogesterone of 150, and an insulin level of 23.1?
What is the recommended treatment regimen for a patient with Polycystic Ovary Syndrome (PCOS), Generalized Anxiety Disorder (GAD), and Pervasive Developmental Disorder (PDD), considering metformin, vortioxetine (Brintellix), and Oral Contraceptive Pills (OCPs)?
What is the significance of a mildly elevated prolactin level in a 38-year-old female with shortened menstrual cycles, in the absence of abdominal pain and genitourinary (genito-urinary) symptoms?
What is the analysis of a patient with hyperprolactinemia, hypotestosteronemia, and impaired glucose regulation?
What is the recommended initial intravenous (IV) dosage of Nicardipine (calcium channel blocker) for treating hypertension?
Should a patient with dengue fever, thrombocytopenia (platelet count of 36,000), and menstruation receive a platelet transfusion?
What is the role of Gonadotropin-releasing hormone (GnRH) agonist in luteal support during Frozen Embryo Transfer (FET) cycles?
What is the recommended treatment for vitamin B12 deficiency?
What is the immediate management for post CPR (Cardiopulmonary Resuscitation) anoxic brain injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.